Trial design in "magnesium sulphate in aneurysmal subarachnoid hemorrhage: A randomized controlled trial" [7]

Stroke

Volumn 36, Issue 12, 2005, Pages 2530-2531

  Wong, George K C ^a   Boet, Ronald ^a   Poon, W S ^a   Chan, Matthew T V ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; MAGNESIUM SULFATE; NEUROPROTECTIVE AGENT;

BRAIN ARTERY ANEURYSM; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; HUMAN; LETTER; NEUROPROTECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; ANIMAL; FOLLOW UP; METHODOLOGY; NOTE;

ANIMALS; BRAIN ISCHEMIA; FOLLOW-UP STUDIES; HUMANS; MAGNESIUM SULFATE; NEUROPROTECTIVE AGENTS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 33644672431     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000190091.36915.84     Document Type: Letter

References (4)

1. van den Bergh WM; on behalf of the MASH Study Group. Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage. Stroke. 2005;36:1011-1015.
2. van den Bergh WM (contact). Magensium and Acetylsalicylic acid in Subarachnoid Hemorrhage (MASH). Stroke. 2002;33:646-655.
3. Rabinstein AA, Weigand S, Atkinson JLD, Wijdicks EFM. Patterns of Cerebral Infarction in Aneurysmal Subarachnoid Hemorrhage. Stroke. 2005;36:992-997.
4. Boet R, Chan MTV, Poon WS, Wong GKC, Wong HT, Gin T. Intravenous Magnesium Sulphate to improve outcome after aneurysmal subarachnoid hemorrhage. Acta Neurochir. 2005 (In press).